JPRN-UMIN000009183尚未招募未知
The comparison of Eldecalcitol and Alfacalcidol on early osteoporosis caused by Anastrozole / Letrozole for post-operative breast cancer. - The comparison of Eldecalcitol and Alfacalcidol on early osteoporosis caused by Anastrozole / Letrozole for post-operative breast cancer.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Using other osteoporosis drugs within 6 months 2. Patients suffered from malignancies except mammary carcinoma. 3. Patients with contraindication for eldecalcitol treatments 4. Patients who have serum calcium levels of above 10.4mg/dL. 5. Patients judged inappropriate by attending physicians.
研究者
相似试验
招募中
3 期
Calcitriol and cholecalciferol effect on cardiac biomarkersIRCT20150518022306N3Shiraz University of Medical Sciences180
尚未招募
不适用
The effect of switching to Eldecalcitol from Alfacalcidol on osteoporosis caused by Anastrozole / Letrozole for post-operative breast cancer.JPRN-UMIN000009182Kansai Medical University35
已完成
不适用
The beneficial effect and safety Eldecalcitol with combined peginterferon alpha-2a plus ribavirin for chronic hepatitis C patients with osteoporosisJPRN-UMIN000007070Department of Hepatology, Osaka City University Graduate School of Medicine50
已完成
不适用
Quantitative assessment of the eldecalcitol effect on intestinal calcium absorptioPrimary osteoporosisJPRN-UMIN000020267Research secretariat (IDD, Inc.)40
进行中（未招募）
1 期
Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard ChemotherapyMedDRA version: 20.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000012984Acute Myeloid LeukemiaEUCTR2015-002983-18-BEHybrigenics S.A.110